Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sorrento Therapeutics Inc
(NQ:
SRNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sorrento Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
Market Briefing For Monday, Aug. 23
August 23, 2021
We might be near a moment of truth for the Senior Indexes, either in just a few days or postponed until after Labor Day.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
August 20, 2021
Gainers Geovax Labs (NASDAQ:GOVX) shares...
Via
Benzinga
Market Briefing For Tuesday, Aug. 17
August 17, 2021
Momentum grows for a Fed taper. Investor risk now is no more than just a couple weeks ago. Actually a Fed movement is a plus as it suggest they're a believe in economic growth; which will be favorable...
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Why Sorrento Therapeutics' Stock Is Trading Higher Today
July 21, 2021
Sorrento Therapeutics (NASDAQ:SRNE) shares are trading hig...
Via
Benzinga
Market Briefing For Wednesday, July 21
July 21, 2021
Via
Talk Markets
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Monday, Aug. 16
August 16, 2021
Too many permabears are almost delirious with negativity and still give extremely bearish outlooks, when that's not a correct read of markets.
Via
Talk Markets
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
August 14, 2021
Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to...
Via
Talk Markets
Why Dynavax, Novavax, and Sorrento Soared This Week
August 13, 2021
There were different reasons behind each of these COVID-19 vaccine stocks' big gains.
Via
The Motley Fool
Exposures
COVID-19
Market Briefing For Thursday, Aug. 12
August 12, 2021
Fear and hysteria are not engineered by Washington about COVID, however it is a 'mood' to factor into everything from media to stock market projections.
Via
Talk Markets
Dyadic Stock Jumps On Development Pact With Sorrento For Diagnostics & Therapies For Coronaviruses
August 11, 2021
Dyadic International Inc (NASDAQ: DYAI) and Sorrento Therapeutics Inc (NASDAQ: SRNE) have announced a binding term sheet for a License Agreement to...
Via
Benzinga
Market Briefing For Tuesday, Aug. 10
August 10, 2021
Most markets held gains as the total backdrop has not changed. Lots of money managers are eager to see a decline, to put more money 'in', but the market hasn't cooperated by dropping 'much'.
Via
Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Thinking About Buying Stock In AMD, General Motors Or Sorrento Therapeutics?
August 09, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I...
Via
Benzinga
Market Briefing For Monday, Aug. 9
August 09, 2021
Ultimately energy markets will envision post-pandemic era robust economic activity resuming, even though Covid surges temporarily squelch demand.
Via
Talk Markets
Cramer Advises Viewers On Palantir, SoFi And More
August 04, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer....
Via
Benzinga
Market Briefing For Wednesday, Aug. 4
August 04, 2021
'Subject to mandate' seems to be a catch-phrase these days; mandates to fly, to eat, to drink in a pub, to go to a show, and even to govern New York (of course that last one was an effort at humor,...
Via
Talk Markets
Market Briefing For Tuesday, Aug. 3
August 03, 2021
We do see Tuesday turnaround as a rebound from Monday's just modest fade. Again our wildcard continues to be Covid; and the 'presumed' dovish Fed as relates to 'tapering'.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Sorrento Therapeutics To Start Testing DAR-T Cell Therapy In Multiple Myeloma Patients
August 02, 2021
The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) IND application for the Phase 1 clinical testing of its allogeneic anti-CD38 Dimeric Antigen...
Via
Benzinga
Exposures
Product Safety
Market Briefing For Monday, Aug. 2
August 02, 2021
We're 'not' in a global financial crisis; but we are failing the 'synchronized global recovery', due to the worldwide pandemic.
Via
Talk Markets
Market Briefing For Thursday, July 29
July 29, 2021
Disarming SARS-CoV-2 with pharmaceutical drugs is the 'holy grail' to end the COVID-19 panic, and generally eliminate the panic pressures for vaccines.
Via
Talk Markets
Exposures
COVID-19
Market Briefing For Wednesday, July 28
July 28, 2021
Tolls being taken out of the market for those overstaying not just Chinese stocks, but the S&P and NDX behemoths as well. Solid earnings are 'in the mix' (discounted) of course, and it's the guidance...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Briefing For Thursday, July 22
July 22, 2021
The post-COVID era has not arrived yet, and that cuts to the chase of what's bothering markets and prospects for the economy. The optimistic hope is to keep everything open on a presumed basis, because...
Via
Talk Markets
Topics
Economy
Exposures
Economy
Unusual Options Activity Insight: Sorrento Therapeutics
July 21, 2021
Shares of Sorrento Therapeutics (NASDAQ:SRNE) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $9.16. Sentiment:...
Via
Benzinga
Sorrento Starts Patient Dosing In Mid-Stage COVID-19 Trial With Nasal Neutralizing Antibody
July 21, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) has started dosing COVID-19 patients in its Phase 2 efficacy trial. This study uses a decentralized design where...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Wednesday, July 14
July 14, 2021
Negative divergences increasingly creeping into the NY market are reflected a good bit by the S&P shuffles, and overall big-board technicals. Though, yields were up with a mediocre Treasury Auction,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Unusual Options Activity Insight: Sorrento Therapeutics
July 12, 2021
On Monday, shares of Sorrento Therapeutics (NASDAQ:SRNE) saw unusual options activity. After the option alert, the stock price moved down to $8.31. Sentiment: BULLISH Option...
Via
Benzinga
Why Sorrento Therapeutics Is Down 9% This Week
July 08, 2021
Investors apparently weren't impressed by good news about the company's promising RTX.
Via
The Motley Fool
Why Sorrento Therapeutics Stock Gained 29% Last Month
July 08, 2021
The rally has more to do with the stock's pre-June circumstances than recent news.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.